| Dec 10, 2025 |
Dec 12, 2025 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
40.0
|
-20,000
|
-1.62%
|
✓
|
$1.5M |
| Dec 4, 2025 |
Dec 5, 2025 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
32.5
|
-40,000
|
-3.14%
|
✓
|
$3M |
| Nov 13, 2025 |
Nov 13, 2025 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
40.0
|
-20,000
|
-1.55%
|
✓
|
$1.3M |
| Mar 5, 2025 |
Mar 7, 2025 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
45.0
|
-10,000
|
-0.77%
|
✓
|
$301.5K |
| Feb 5, 2025 |
Feb 7, 2025 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-15,000
|
-1.14%
|
✓
|
$608.7K |
| Jan 8, 2025 |
Jan 10, 2025 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-15,000
|
-1.13%
|
✓
|
$732.7K |
| Dec 4, 2024 |
Dec 6, 2024 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-15,000
|
-1.12%
|
✓
|
$698.7K |
| Nov 6, 2024 |
Nov 8, 2024 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-15,000
|
-1.11%
|
✓
|
$888.3K |
| Oct 2, 2024 |
Oct 4, 2024 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
36.3
|
-40,000
|
-2.87%
|
✓
|
$2.2M |
| Sep 4, 2024 |
Sep 6, 2024 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
36.3
|
-40,000
|
-2.79%
|
✓
|
$1.9M |
| Aug 7, 2024 |
Aug 9, 2024 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
36.3
|
-40,000
|
-2.71%
|
✓
|
$1.6M |
| Jul 5, 2024 |
Jul 5, 2024 |
Apogee Therapeutics, Inc.
|
CEO |
Sell |
42.5
|
-15,000
|
-1.01%
|
✓
|
$558.9K |
| Dec 1, 2020 |
Dec 2, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
35.0
|
-10,000
|
-3.52%
|
✓
|
$515.2K |
| Jun 3, 2020 |
Dec 2, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
52.5
|
-784
|
-0.30%
|
✓
|
$23.5K |
| Nov 16, 2020 |
Nov 18, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
38.8
|
-16,353
|
-2.93%
|
✓
|
$731.6K |
| Nov 2, 2020 |
Nov 3, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
35.0
|
-10,000
|
-3.60%
|
✓
|
$383.6K |
| Oct 1, 2020 |
Oct 5, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
35.0
|
-10,000
|
-3.60%
|
✓
|
$388.3K |
| Sep 18, 2020 |
Sep 22, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
35.0
|
-10,000
|
-3.60%
|
✓
|
$400K |
| Sep 1, 2020 |
Sep 3, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
35.0
|
-10,000
|
-3.60%
|
✓
|
$287.3K |
| Aug 16, 2020 |
Aug 18, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
22.5
|
-5,460
|
-2.00%
|
✗
|
$155.8K |
| Aug 3, 2020 |
Aug 5, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
35.0
|
-10,000
|
-3.70%
|
✓
|
$273.7K |
| Jul 1, 2020 |
Jul 6, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
35.0
|
-10,000
|
-3.70%
|
✓
|
$309.7K |
| Jun 8, 2020 |
Jun 10, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
53.8
|
-606
|
-0.23%
|
✓
|
$18.2K |
| Jun 1, 2020 |
Jun 3, 2020 |
BridgeBio Pharma, Inc.
|
Chief Business Officer |
Sell |
47.5
|
-2,585
|
-0.98%
|
✓
|
$75.9K |
| May 5, 2020 |
May 6, 2020 |
BridgeBio Pharma, Inc.
|
Officer |
Sell |
51.3
|
-1,460
|
-0.89%
|
✓
|
$44.5K |
| May 1, 2020 |
May 5, 2020 |
BridgeBio Pharma, Inc.
|
Officer |
Sell |
41.3
|
-3,905
|
-2.33%
|
✓
|
$115.3K |
| Apr 1, 2020 |
Apr 3, 2020 |
BridgeBio Pharma, Inc.
|
Officer |
Sell |
45.0
|
-2,585
|
-1.52%
|
✓
|
$69.6K |
| Mar 2, 2020 |
Mar 4, 2020 |
BridgeBio Pharma, Inc.
|
Officer |
Sell |
41.3
|
-3,975
|
-2.28%
|
✓
|
$129K |
| Feb 3, 2020 |
Feb 5, 2020 |
BridgeBio Pharma, Inc.
|
Officer |
Sell |
41.3
|
-3,975
|
-2.23%
|
✓
|
$138.7K |
| Jan 2, 2020 |
Jan 6, 2020 |
BridgeBio Pharma, Inc.
|
Officer |
Sell |
41.3
|
-3,975
|
-2.18%
|
✓
|
$131.9K |
| Jul 1, 2019 |
Jul 3, 2019 |
BridgeBio Pharma, Inc.
|
Officer |
Buy |
87.5
|
+7,000
|
4.03%
|
✗
|
$119K |